homocysteine has been researched along with gemfibrozil in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JK; Blumenthal, aR; Nass, CM; Post, WS; Wiviott, SD | 1 |
Dierkes, J; Luley, C; Westphal, S | 1 |
Bostom, AG | 1 |
Chan, NN; Chow, FC | 1 |
Frick, MH; Humphries, SE; Kesäniemi, YA; Nieminen, MS; Pasternack, A; Syvänne, M; Taskinen, MR; Turpeinen, U; Whittall, RA | 1 |
Contant, CF; Francone, OL; Gao, X; Lewin, AJ; Nguyen, TT; Terra, SG | 1 |
3 trial(s) available for homocysteine and gemfibrozil
Article | Year |
---|---|
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Topics: Adult; Aged; Creatinine; Cross-Over Studies; Cystatin C; Cystatins; Fenofibrate; Gemfibrozil; Homocysteine; Humans; Hypertriglyceridemia; Lipids; Male; Middle Aged | 2001 |
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
Topics: Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Triglycerides | 2004 |
Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein B-100; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Female; Fenofibrate; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; PPAR alpha | 2008 |
3 other study(ies) available for homocysteine and gemfibrozil
Article | Year |
---|---|
Global risk assessment for lipid therapy to prevent coronary heart disease.
Topics: Blood Flow Velocity; Carotid Arteries; Coronary Disease; Exercise Test; Gemfibrozil; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Risk Assessment; Risk Factors; Tunica Intima | 2000 |
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Topics: Creatinine; Fenofibrate; Gemfibrozil; Glomerular Filtration Rate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Reproducibility of Results | 2001 |
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Topics: Fenofibrate; Fibrinogen; Gemfibrozil; Homocysteine; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2001 |